The global congenital hyperinsulinism treatment market reached a value of USD 160.61 Million in 2024. Driven by rising awareness and a strong pipeline of treatments worldwide, the market is projected to grow at a CAGR of 4.80% during 2025-2034, reaching about USD 256.68 Million by 2034. https://www.expertmarketresearch.com/reports/congenital-hyperinsulinism-market